P21/WAF1 mutation and drug resistance to paclitaxel in locally advanced breast cancer

Int J Cancer. 2007 Jun 15;120(12):2749. doi: 10.1002/ijc.22595.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics*
  • Drug Resistance, Neoplasm / genetics*
  • Female
  • Humans
  • Mutation*
  • Neoplasm Staging
  • Paclitaxel / pharmacology
  • Paclitaxel / therapeutic use*
  • Polymorphism, Genetic

Substances

  • Antineoplastic Agents, Phytogenic
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Paclitaxel